Oxford Biomedica Share Discussion Threads

[badger60] 14/7/2022 15:44

Mint
That's mind-blowing!!!
I have not been vaxxed (filth!)
I've been taking ivermectin as a preventative/cure for covid and can personally vouch that it works very well.


It may well be the case that I have inadvertently been protecting myself against various forms of cancer as well!!!!

Ivermectin cost me just over 2 quid for 100 x 5 mg tablets!.......so I bought 40 and gave them to friends and family who refused to be jabbed. Not one of them (3), including me, has suffered much and completely recovered from covid within 5 days.....
Now it's being touted by the NIH as a serious contender to be a cure for cancer !!!!!!

A fantastic link!!!

[marcusl2] 14/7/2022 15:13

Gene Therapy
@GeneTherapy_SN
·
7m
The world's first single-dose #genetherapy to treat #HaemophiliaA,
@BioMarin
's Roctavian received EMA conditional marketing authorisation. Roctavian will be the worlds most expensive drug estimated by
@icer_review
to be $2.5million per dose.

[antreg] 14/7/2022 14:03

Agreed Harry.

[harry s truman] 14/7/2022 13:41

Read it quite a while ago now Antreg (The Real Anthony Fauci) and didn't have to get past chapter one (where they trashed the reputation of the existing approved drugs).

As always it's follow the money - but this is a global scandal which you and I can do little about. History will be written by the victors once more and kids will be told that it was worth destroying their education and saddling them with debt because of the lives saved amongst people who were almost always chronically ill with something else.

We're here for OXB though and one of these days they will announce a good deal. It might kill some of us with shock, but they will do it.

[badger60] 14/7/2022 13:09

MintWell said. I couldn't agree more as through personal experience and looking around the jab brigade, especially Pfizer were making Billions in profit. I don't know if AZN made much as they had dangerous side effect issues with their Vax. I know that in Canada and some manufacturers had to dump millions of stockpiled jabs because they were out of date.Imo I can't see OXB getting anything more out of AZN, despite the lukewarm RNS.

[antreg] 14/7/2022 12:11

Before any forecasts please read Dr Anthony Fauci by Robert F. Kennedy Jr. Yes the Kennedy family. An absolute must read for facts.

[badger60] 14/7/2022 12:04

Oops...not a good day today....... perhaps people are waking up to the huge risk profile that OXB now has............

[harry s truman] 14/7/2022 10:06

AstraZeneca's COVID-19 vaccine saved 6.3 million lives in the first year of the rollout, and Pfizer and BioNTech's shot saved 5.9 million, according to a new data analysis.



UPDATED: Wednesday, July 13 at 10:45 a.m. ET

A new analysis from London-based data firm Airfinity found that AstraZeneca’s COVID-19 vaccine saved 6.3 million lives in the first year of the rollout, with Pfizer and BioNTech’s shot saving 5.9 million. Coronavirus vaccines together saved about 20 million lives in the first year, more than half of them in wealthier countries, Bloomberg reports. Airfinity determined that Sinovac and Moderna vaccines saved about 2 million and 1.7 million lives, respectively.

[harry s truman] 14/7/2022 09:38

Dom,

The (almost) worldwide reaction Covid seems to have created something now in a lot of previously rational people which can never be tamed, which is very sad really.

From what I've read in the FT, Pfizer's living with covid drug Paxlovid - i.e. the drug which they will sell now covid is with us forever - just doesn't work for most people.

Search on the interweb for Pfizer's EPIC-SR trial and you'll see some really sketchy claimed benefits (much like their emergency use vaccine), but it is being widely prescribed and even mentioned in Biden's state of the union address.

Now I realise that he just reads what they stand him in front of, but how can the likes of AZ compete with a company which can get a sitting US president to push a drug which does nothing for most people and might actually cause rebound problems when they stop taking the drug which wasn't helping them anyway?

The obvious answer is that we can't. Coronavirus is such a cash cow that the people who really benefit from it will never let it go. Sadly we are aligned with a university and company who tried to do the right thing.

What OXB needs more than anything is some news regarding vectors. This is what our company does and even though we are world leaders with lots of capacity coming online, we have had not vector news since the beginning of January.

[dominiccummings] 13/7/2022 22:08

So we are dependent on an uncertainty that AZ have with the market for Covid vaccines.
It would be helpful if there were any information with regard to an updated vaccine?

[harry s truman] 13/7/2022 19:19

13 Jul 2022

Stephenson Harwood advises Oxford Biomedica on new AstraZeneca agreement

Law firm Stephenson Harwood LLP has advised Oxford Biomedica, the gene and cell therapy company, on its new three year Master Services & Development Agreement with AstraZeneca UK Ltd (AstraZeneca), which would facilitate potential future manufacturing opportunities for the AstraZeneca COVID-19 vaccine.

This deal represents an expansion of the original Master Supply and Development Agreement announced between the two companies in September 2020, on which Stephenson Harwood also advised.

The manufacture of COVID-19 vaccines at Oxford Biomedica’s Oxbox facility is expected to complete in the last quarter of 2022, as part of the original commitment. In accordance with the terms of the original agreement, and inclusive of revenues for batches already manufactured in the first half of 2022, Oxford Biomedica expects to recognise aggregate revenues of approximately £30 million from AstraZeneca in the current financial year.

Under the new agreement, manufacturing of vaccines at Oxford Biomedica’s world class 84,000 sq. ft manufacturing facility, Oxbox, will be available to AstraZeneca on an as needed basis beyond 2022.

The Stephenson Harwood team was led by commercial partner Dan Holland, with support from senior associate Chloe Haywood and associate Bobbie Bickerton. Further assistance was provided by partner Alexandra Pygall who assisted on the intellectual property aspects of the deal.

[badger60] 13/7/2022 09:59

From "The Guardian""More than 200,000 Covid deaths have been recorded across the UK, according to figures from the Office for National Statistics.A total of 200,247 Covid deaths have occurred, with 294 in the last week. The figures include deaths due to Covid-19 as well as those involving the virus".It's a shame they don't supply figures of those that have died or are severely handicapped due to the effects of being vaxxed........of course they won't......they don't want to tell humanity that they've been deliberately poisoned by greedy big pharma, ably assisted by their political puppets.

[badger60] 13/7/2022 09:18

Does anybody really believe what these greedy covid vax manufacturers say about the efficacy of their own products. They all have been lying about it since day one. Initially 1 jab provided complete protection, according to them. Now more people who have been jabbed are getting covid than those that haven't......as well as all the nasty/lethal long term after effects that goes with it. Novak Djokovic told them to stuff it for good reason.
We take ivermectin and (so far) a very few of us (including me) have been infected with mild symptoms with a complete recovery within max 4-5 days, and no long covid fall out. Once you're vaxxed you can't get unvaxxed.

[pharmaboy3] 13/7/2022 08:40

So, real data proves we are just as effective as mRNAsHTTps://m.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/AstraZeneca-says-COVID-vaccine-as-effective-as-mRNA-shots-in-review-40969661/

[badger60] 13/7/2022 04:40

This is a worrying aspect, the profit margin and the amount of revenue needed to be a profitable company. An operating profit of 21 Mio from revenues of 143 mio is hardly anything to get excited about and the net profit would be much lower. If you're invested here for a dividend forget it. OXB are set up to be dependent on 3rd party manufacturing contracts....which isn't happening ........and their drug pipeline is mainly in the early stages of very expensive development. Homology is even worse with annual running costs of circa USD 150 Mio, and no revenue."The AZN COVID-19 deal has buoyed OXB's revenues in recent years. It reported FY21 revenue of £142.8m, up 63% from £87.7m in FY20, and generated an operating profit of £20.8m (FY20: £5.69m loss), which management largely attributes to manufacturing revenues from the AZN deal".

[harry s truman] 12/7/2022 19:05

In November (2020), the Group entered into a gene therapy discovery collaboration with PhoreMost to develop next-generation CAR-T cell therapies with improved efficacy and durability. This will use PhoreMost's SITESEEKER platform to identify active peptides to be deployed within the Group's LentiVector® delivery system.

Not sure if it has any relevance to us but there is a 5 minute read out on PhoreMost today

[harry s truman] 12/7/2022 14:14

Lowering LDL sounds great Marcus, but with a one shot treatment that they can't reverse and for something which is presumably already treatable with a statin tablet? Let's hope that it's a very thorough test (unlike some products we have seen rushed through recently).

[marcusl2] 12/7/2022 11:35

Oxford Biomedica Retweeted
UK Research and Innovation
@UKRI_News
·
Jul 7
How has cell & gene therapy, advanced therapies and medicines manufacturing evolved in the last few years?

Learn more at the free UKRI medicines manufacturing showcase on 12 July and hear from companies including
@OxfordBiomedica
,
@Phicotx
&
@QuotientHQ
:

[harry s truman] 12/7/2022 09:39

squids,

I'm off out now, but I don't think the machines have any kind of human input or even a way to look at news - I think they just trade trends. Sometimes it all goes wrong and they chase their tails which can lead to trading breaks in the market where it all gets reset.

Should we get really good news one morning about anything, then the bots would simply be chasing an upward trend that day.

[harry s truman] 12/7/2022 09:35

Effham, I understood what you meant - no worries.

===

Lockkeeper, I realise I have a glass half-full but OXB have told us that they have 2 people interested in the PD drug which Sio/Axovant couldn't afford to continue with. They are setting up the clinical trial now for CAR-T 5t4. Their lenitvector IP and the patents around the processing are key to many promising therapies and one approved one, yet people like JP like to pigeon hole OXB as simply hiring manufacturing space and people to others. I think it's a lazy description, but to be fair bioprocessing and codevelopment is definitely a big part of our business now.

[squidsgone] 12/7/2022 09:34

I wonder if we could surmise then that when the selling algos stop, than a positive RNS may be imminent, (or conversely, when they continue, not).